CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-01

Study Completion Date

2034-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Early diagnosis of cancer allows for better treatment outcomes, higher survival rates, and lower costs of care. It is shown that cancer monitoring for cancer in at-risk populations is a key component in early diagnosis. The HMH Hennessey Institute for Cancer prevention and Applied Molecular Science (HICAP) is a newly founded institute, providing clinical services for cancer screening and risk assessment to the community, as well as research in cancer risk and prevention. The CanScan registry will prospectively collect data from participants in the form of questionnaires. The registry will also capture data that is collected as per non-research assessments, for participants who consent to participate. The registry will facilitate better understanding of cancer risk, screening, and diagnostics.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer

NCT00001163

Hereditary Neoplasms Cancer Genetic Predisposition to Cancer +1 more

ACTIVE_NOT_RECRUITING

Head and Neck Cancer Screening and Serum Repository

NCT00592371

Head and Neck Squamous Cell Cancer

COMPLETED

CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2

NCT03253575

Adult Solid Tumor

SUSPENDED

Study of Healthy Cohort for Early Detection of Cancer

NCT05193305

Healthy

RECRUITING

Single-institution Register of Individuals Undergoing Cancer Genetic Risk Assessment

NCT06800599

Genetic Predisposition to Cancer

ENROLLING_BY_INVITATION

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Risk

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults ( 18 and older)
* Ability to provide own consent
* Must meet at least one of the below criteria, Indicating an increased risk for cancer, any of the following:

* Family or personal history suggests a familial/hereditary disorder known or suspected of predisposition to cancer.
* Personal factors associated with an increased risk for cancer include benign breast disease, polyps, tobacco use, etc.as defined by the investigator.
* Family members of participating individuals.
* Any participant in the HICAP program regardless of cancer risk

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes